Uptake of novel evidence-based therapies in patients with type 2 diabetes after a cardiovascular event: insights from CANHEART by Wade Thompson, PharmD, PhD, Brendan Wong, MD, Atul Sivaswamy, MSc, Laura Ferreira-Legere, MScN, Douglas S. Lee, MD, PhD, Husam Abdel-Qadir, MD, PhD, Dennis T. Ko, MD, MSc, Alanna Weisman, MD, PhD, Sheldon Tobe, MD, MSc, Cynthia A. Jackevicius, PharmD, MSc, Shaun G. Goodman, MD, MSc, Michael E. Farkouh, MD, Jacob A. Udell, MD, MPH

Get full text